Form 4: Jay Siegel Reports Macrogenics Stock Transactions

Jay Philip Siegel, a Director at Macrogenics Inc., reported a transaction involving 3,750 shares of common stock on May 18, 2026.

Summary

• Jay Philip Siegel, a Director at Macrogenics Inc., reported a transaction on May 18, 2026.
• The transaction involved the acquisition of 3,750 shares of common stock.
• Following this transaction, Mr. Siegel beneficially owns 14,750 shares of common stock.
• The acquisition was related to the vesting of Restricted Stock Units (RSUs).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine insider transaction related to RSU vesting rather than a significant strategic event or financial performance indicator.

Positives

• Director Jay Philip Siegel acquired additional shares, indicating potential confidence in the company.
• The acquisition of 3,750 shares of common stock through RSU vesting suggests a reward mechanism for management.

Future Outlook

This filing does not contain forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, providing transparency into the holdings and activities of company directors and officers. This specific filing details the vesting of Restricted Stock Units for a director, a common practice in executive compensation.

Stakeholder Impact

• Shareholders: Increased transparency into director's beneficial ownership following RSU vesting.

Key Dates

Keywords

Form 4, SEC Filing, Insider Transaction, Macrogenics Inc, MGNX, Jay Philip Siegel, Common Stock, Restricted Stock Units, RSU Vesting, Beneficial Ownership